Prognostic significance of proteinuria in stroke patients treated with intravenous thrombolysis.
Saved in:
| Title: | Prognostic significance of proteinuria in stroke patients treated with intravenous thrombolysis. |
|---|---|
| Authors: | Gensicke, H., Frih, A. A., Strbian, D., Zini, A., Pezzini, A., Padjen, V., Haueter, M., Seiffge, D. J., Mäkitie, L., Traenka, C., Poli, L., Martinez ‐ Majander, N., Putaala, J., Bonati, L. H., Sibolt, G., Giovannini, G., Curtze, S., Beslac ‐ Bumbasirevic, L., Vandelli, L., Lyrer, P. A. |
| Source: | European Journal of Neurology. Feb2017, Vol. 24 Issue 2, p262-269. 8p. |
| Subjects: | Proteinuria diagnosis, Stroke patients, Thrombolytic therapy, Glomerular filtration rate, Intravenous therapy, Cerebral hemorrhage, Mortality risk factors |
| Abstract: | Background and purpose Proteinuria and estimated glomerular filtration rate ( eGFR) are indicators of renal function. Whether proteinuria better predicts outcome than eGFR in stroke patients treated with intravenous thrombolysis ( IVT) remains to be determined. Methods In this explorative multicenter IVT register based study, the presence of urine dipstick proteinuria (yes/no), reduced eGFR (<60 ml/min/1.73 m2) and the coexistence of both with regard to (i) poor 3-month outcome (modified Rankin Scale score 3-6), (ii) death within 3 months and (iii) symptomatic intracranial hemorrhage ( ECASS- II criteria) were compared. Unadjusted and adjusted odds ratios ( ORs) with 95% confidence intervals were calculated. Results Amongst 3398 patients, 881 (26.1%) had proteinuria and 623 (18.3%) reduced eGFR. Proteinuria [ ORadjusted 1.65 (1.37-2.00) and ORadjusted 1.52 (1.24-1.88)] and reduced eGFR [ ORadjusted 1.26 (1.01-1.57) and ORadjusted 1.34 (1.06-1.69)] were independently associated with poor functional outcome and death, respectively. After adding both renal markers to the models, proteinuria [ ORadjusted+eGFR 1.59 (1.31-1.93)] still predicted poor outcome whilst reduced eGFR [ ORadjusted+proteinuria 1.20 (0.96-1.50)] did not. Proteinuria was associated with symptomatic intracranial hemorrhage [ ORadjusted 1.54 (1.09-2.17)] but not reduced eGFR [ ORadjusted 0.96 (0.63-1.62)]. In 234 (6.9%) patients, proteinuria and reduced eGFR were coexistent. Such patients were at the highest risk of poor outcome [ ORadjusted 2.16 (1.54-3.03)] and death [ ORadjusted 2.55 (1.69-3.84)]. Conclusion Proteinuria and reduced eGFR were each independently associated with poor outcome and death but the statistically strongest association appeared for proteinuria. Patients with coexistent proteinuria and reduced eGFR were at the highest risk of poor outcome and death. [ABSTRACT FROM AUTHOR] |
| Copyright of European Journal of Neurology is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) | |
| Database: | Psychology and Behavioral Sciences Collection |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: pbh DbLabel: Psychology and Behavioral Sciences Collection An: 120810685 AccessLevel: 6 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Prognostic significance of proteinuria in stroke patients treated with intravenous thrombolysis. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Gensicke%2C+H%2E%22">Gensicke, H.</searchLink><br /><searchLink fieldCode="AR" term="%22Frih%2C+A%2E+A%2E%22">Frih, A. A.</searchLink><br /><searchLink fieldCode="AR" term="%22Strbian%2C+D%2E%22">Strbian, D.</searchLink><br /><searchLink fieldCode="AR" term="%22Zini%2C+A%2E%22">Zini, A.</searchLink><br /><searchLink fieldCode="AR" term="%22Pezzini%2C+A%2E%22">Pezzini, A.</searchLink><br /><searchLink fieldCode="AR" term="%22Padjen%2C+V%2E%22">Padjen, V.</searchLink><br /><searchLink fieldCode="AR" term="%22Haueter%2C+M%2E%22">Haueter, M.</searchLink><br /><searchLink fieldCode="AR" term="%22Seiffge%2C+D%2E+J%2E%22">Seiffge, D. J.</searchLink><br /><searchLink fieldCode="AR" term="%22Mäkitie%2C+L%2E%22">Mäkitie, L.</searchLink><br /><searchLink fieldCode="AR" term="%22Traenka%2C+C%2E%22">Traenka, C.</searchLink><br /><searchLink fieldCode="AR" term="%22Poli%2C+L%2E%22">Poli, L.</searchLink><br /><searchLink fieldCode="AR" term="%22Martinez+‐+Majander%2C+N%2E%22">Martinez ‐ Majander, N.</searchLink><br /><searchLink fieldCode="AR" term="%22Putaala%2C+J%2E%22">Putaala, J.</searchLink><br /><searchLink fieldCode="AR" term="%22Bonati%2C+L%2E+H%2E%22">Bonati, L. H.</searchLink><br /><searchLink fieldCode="AR" term="%22Sibolt%2C+G%2E%22">Sibolt, G.</searchLink><br /><searchLink fieldCode="AR" term="%22Giovannini%2C+G%2E%22">Giovannini, G.</searchLink><br /><searchLink fieldCode="AR" term="%22Curtze%2C+S%2E%22">Curtze, S.</searchLink><br /><searchLink fieldCode="AR" term="%22Beslac+‐+Bumbasirevic%2C+L%2E%22">Beslac ‐ Bumbasirevic, L.</searchLink><br /><searchLink fieldCode="AR" term="%22Vandelli%2C+L%2E%22">Vandelli, L.</searchLink><br /><searchLink fieldCode="AR" term="%22Lyrer%2C+P%2E+A%2E%22">Lyrer, P. A.</searchLink> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22European+Journal+of+Neurology%22">European Journal of Neurology</searchLink>. Feb2017, Vol. 24 Issue 2, p262-269. 8p. – Name: Subject Label: Subjects Group: Su Data: <searchLink fieldCode="DE" term="%22Proteinuria+diagnosis%22">Proteinuria diagnosis</searchLink><br /><searchLink fieldCode="DE" term="%22Stroke+patients%22">Stroke patients</searchLink><br /><searchLink fieldCode="DE" term="%22Thrombolytic+therapy%22">Thrombolytic therapy</searchLink><br /><searchLink fieldCode="DE" term="%22Glomerular+filtration+rate%22">Glomerular filtration rate</searchLink><br /><searchLink fieldCode="DE" term="%22Intravenous+therapy%22">Intravenous therapy</searchLink><br /><searchLink fieldCode="DE" term="%22Cerebral+hemorrhage%22">Cerebral hemorrhage</searchLink><br /><searchLink fieldCode="DE" term="%22Mortality+risk+factors%22">Mortality risk factors</searchLink> – Name: Abstract Label: Abstract Group: Ab Data: Background and purpose Proteinuria and estimated glomerular filtration rate ( eGFR) are indicators of renal function. Whether proteinuria better predicts outcome than eGFR in stroke patients treated with intravenous thrombolysis ( IVT) remains to be determined. Methods In this explorative multicenter IVT register based study, the presence of urine dipstick proteinuria (yes/no), reduced eGFR (<60 ml/min/1.73 m2) and the coexistence of both with regard to (i) poor 3-month outcome (modified Rankin Scale score 3-6), (ii) death within 3 months and (iii) symptomatic intracranial hemorrhage ( ECASS- II criteria) were compared. Unadjusted and adjusted odds ratios ( ORs) with 95% confidence intervals were calculated. Results Amongst 3398 patients, 881 (26.1%) had proteinuria and 623 (18.3%) reduced eGFR. Proteinuria [ ORadjusted 1.65 (1.37-2.00) and ORadjusted 1.52 (1.24-1.88)] and reduced eGFR [ ORadjusted 1.26 (1.01-1.57) and ORadjusted 1.34 (1.06-1.69)] were independently associated with poor functional outcome and death, respectively. After adding both renal markers to the models, proteinuria [ ORadjusted+eGFR 1.59 (1.31-1.93)] still predicted poor outcome whilst reduced eGFR [ ORadjusted+proteinuria 1.20 (0.96-1.50)] did not. Proteinuria was associated with symptomatic intracranial hemorrhage [ ORadjusted 1.54 (1.09-2.17)] but not reduced eGFR [ ORadjusted 0.96 (0.63-1.62)]. In 234 (6.9%) patients, proteinuria and reduced eGFR were coexistent. Such patients were at the highest risk of poor outcome [ ORadjusted 2.16 (1.54-3.03)] and death [ ORadjusted 2.55 (1.69-3.84)]. Conclusion Proteinuria and reduced eGFR were each independently associated with poor outcome and death but the statistically strongest association appeared for proteinuria. Patients with coexistent proteinuria and reduced eGFR were at the highest risk of poor outcome and death. [ABSTRACT FROM AUTHOR] – Name: AbstractSuppliedCopyright Label: Group: Ab Data: <i>Copyright of European Journal of Neurology is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract.</i> (Copyright applies to all Abstracts.) |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=pbh&AN=120810685 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1111/ene.13179 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 8 StartPage: 262 Subjects: – SubjectFull: Proteinuria diagnosis Type: general – SubjectFull: Stroke patients Type: general – SubjectFull: Thrombolytic therapy Type: general – SubjectFull: Glomerular filtration rate Type: general – SubjectFull: Intravenous therapy Type: general – SubjectFull: Cerebral hemorrhage Type: general – SubjectFull: Mortality risk factors Type: general Titles: – TitleFull: Prognostic significance of proteinuria in stroke patients treated with intravenous thrombolysis. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Gensicke, H. – PersonEntity: Name: NameFull: Frih, A. A. – PersonEntity: Name: NameFull: Strbian, D. – PersonEntity: Name: NameFull: Zini, A. – PersonEntity: Name: NameFull: Pezzini, A. – PersonEntity: Name: NameFull: Padjen, V. – PersonEntity: Name: NameFull: Haueter, M. – PersonEntity: Name: NameFull: Seiffge, D. J. – PersonEntity: Name: NameFull: Mäkitie, L. – PersonEntity: Name: NameFull: Traenka, C. – PersonEntity: Name: NameFull: Poli, L. – PersonEntity: Name: NameFull: Martinez ‐ Majander, N. – PersonEntity: Name: NameFull: Putaala, J. – PersonEntity: Name: NameFull: Bonati, L. H. – PersonEntity: Name: NameFull: Sibolt, G. – PersonEntity: Name: NameFull: Giovannini, G. – PersonEntity: Name: NameFull: Curtze, S. – PersonEntity: Name: NameFull: Beslac ‐ Bumbasirevic, L. – PersonEntity: Name: NameFull: Vandelli, L. – PersonEntity: Name: NameFull: Lyrer, P. A. IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 02 Text: Feb2017 Type: published Y: 2017 Identifiers: – Type: issn-print Value: 13515101 Numbering: – Type: volume Value: 24 – Type: issue Value: 2 Titles: – TitleFull: European Journal of Neurology Type: main |
| ResultId | 1 |